Talking Points

Follow Talking Points
Share on
Copy link to clipboard

A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.

TCTMD


    • May 7, 2025 LATEST EPISODE
    • every other week NEW EPISODES
    • 8m AVG DURATION
    • 179 EPISODES


    Search for episodes from Talking Points with a specific topic:

    Latest episodes from Talking Points

    The REDUCE-AMI Trial

    Play Episode Listen Later May 7, 2025 12:50


    Troels Yndigegn, Sripal Bangalore, and Mamas Mamas discuss whether beta-blockers still benefit patients with acute MI and preserved ejection fraction.

    The EARTH-STEMI Trial

    Play Episode Listen Later Apr 16, 2025 6:16


    Gianluca Campo and C. Michael Gibson compare complete versus culprit-only revascularization in older STEMI patients.

    The SCOFF Trial

    Play Episode Listen Later Apr 9, 2025 7:23


    David Ferreira talks to C. Michael Gibson about the latest data showing patients don't need to fast ahead of cardiac catheterization.

    The RESHAPE-HF2 and MATTERHORN Trials

    Play Episode Listen Later Apr 2, 2025 16:50


    Mamas Mamas, Stefan Anker, and Volker Rudolph talk about their studies of MitraClip for functional MR in patients with heart failure.

    The EMPACT-MI Trial

    Play Episode Listen Later Mar 19, 2025 6:23


    Javed Butler and C. Michael Gibson discuss the trial testing early empagliflozin after acute MI.

    The PROACT Trial

    Play Episode Listen Later Mar 5, 2025 4:24


    Talking with C. Michael Gibson, David Austin reviews the phase III trial of enalapril for anthracycline-induced cardiotoxicity in lymphoma and breast cancer patients.

    The ORBITA-COSMIC Trial

    Play Episode Listen Later Feb 10, 2025 12:45


    Rasha Al-Lamee and Michael Foley sit down with Mamas Mamas to discuss data on an implantable coronary sinus reducer that can ease symptoms in patients with refractory angina.

    The REVIVED-BCIS2 Randomized Trial

    Play Episode Listen Later Feb 4, 2025 6:16


    Looking at the REVIVED-BCIS2 results, Divaka Perera and C. Michael Gibson discuss the relationship between myocardial viability, PCI, and outcomes.

    Ketogenic Diet and Cardiovascular Risk

    Play Episode Listen Later Jan 15, 2025 6:26


    Iulia Iatan talks to C. Michael Gibson about how a low-carbohydrate, high-protein diet can increase plasma lipid levels and cardiovascular risk.

    The CLEAR Outcomes Trial

    Play Episode Listen Later Jan 8, 2025 7:03


    Steven Nissen and C. Michael Gibson discuss using bempedoic acid to reduce MACE in statin-intolerant patients with high cardiovascular risk.

    Inflammatory Risk in Statin-Treated Patients

    Play Episode Listen Later Dec 11, 2024 11:58


    Pooling data from the PROMINENT, REDUCE-IT, and STRENGTH trials, Paul Ridker and C. Michael Gibson discuss the residual inflammatory risks for patients treated with statins.

    The BUDAPEST CRT Upgrade Trial

    Play Episode Listen Later Dec 4, 2024 12:49


    Béla Merkely and C. Michael Gibson discuss the results of a CRT-D upgrade versus ICD alone for HFrEF patients with right ventricular pacing.

    The HEART-FID Trial

    Play Episode Listen Later Nov 20, 2024 4:58


    Robert Mentz and C. Michael Gibson discuss the latest trial to address whether iron supplementation, this time with ferric carboxymaltose, improves outcomes for patients with HF and iron deficiency.

    The FIRE Study

    Play Episode Listen Later Nov 6, 2024 7:59


    Simone Biscaglia and C. Michael Gibson discuss physiology-guided complete revascularization versus culprit-only PCI for elderly patients with acute MI.

    The ECLS-SHOCK Trial

    Play Episode Listen Later Oct 23, 2024 10:15


    Holger Thiele and C. Michael Gibson discuss the impact of VA-ECMO on patients with acute MI and advanced cardiogenic shock.

    The STOPDAPT-3 Trial

    Play Episode Listen Later Oct 9, 2024 9:03


    Masahiro Natsuaki and C. Michael Gibson discuss this latest randomized comparison of prasugrel monotherapy and DAPT with aspirin for patients undergoing PCI.

    The ILUMIEN IV Trial

    Play Episode Listen Later Oct 2, 2024 11:56


    Ziad Ali and C. Michael Gibson take a deeper dive into this comparison of OCT- and angiography-guided PCI.

    OCT vs IVUS vs Angiography: A Meta-analysis

    Play Episode Listen Later Sep 11, 2024 8:05


    Gregg Stone and C. Michael Gibson discuss an updated meta-analysis addressing intravascular imaging in DES implantation.

    The ATTRibute-CM Trial

    Play Episode Listen Later Sep 4, 2024 6:52


    Julian Gillmore and C. Michael Gibson discuss the efficacy of acoramidis for patients with transthyretin amyloid cardiomyopathy.

    The ADVENT Trial

    Play Episode Listen Later Aug 14, 2024 10:28


    Vivek Reddy and C. Michael Gibson compare pulsed field ablation versus thermal ablation for patients with paroxysmal atrial fibrillation.

    The ARAMIS Trial

    Play Episode Listen Later Aug 7, 2024 7:48


    Mathieu Kerneis and C. Michael Gibson compare outcomes of patients treated with anakinra, a new therapy for acute myocarditis, or placebo.

    The NITRATE-CIN Trial

    Play Episode Listen Later Jul 31, 2024 9:50


    Dan Jones and C. Michael Gibson discuss whether inorganic nitrate reduces contrast-induced nephropathy after angiography in ACS patients.

    The DICTATE-AHF Trial

    Play Episode Listen Later Jul 10, 2024 9:33


    Zachary Cox and C. Michael Gibson discuss whether early dapagliflozin initiation is safe and effective for patients with acute heart failure.

    The RIGHT Trial

    Play Episode Listen Later Jul 3, 2024 8:14


    Shaoping Nie, Gilles Montalescot, and C. Michael Gibson discuss prolonged anticoagulation after primary PCI for patients with MI.

    Four-Year Results: The EVOLUT Low Risk Trial

    Play Episode Listen Later Jun 12, 2024 5:51


    Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to self-expanding TAVI or SAVR.

    The AGENT IDE Trial

    Play Episode Listen Later Jun 5, 2024 10:29


    Robert W. Yeh and C. Michael Gibson discuss the primary outcomes of this eagerly awaited trial comparing the AGENT paclitaxel-coated balloon with conventional balloon angioplasty for in-stent restenosis.

    The TRISCEND II Trial

    Play Episode Listen Later May 22, 2024 6:50


    Susheel K. Kodali and C. Michael Gibson discuss transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation.

    The VIVA Trial

    Play Episode Listen Later May 15, 2024 5:00


    Josep Rodés-Cabau and C. Michael Gibson discuss the benefits of TAVI versus SAVR in patients with severe aortic stenosis and small aortic annuli.

    The SELECT Trial

    Play Episode Listen Later May 1, 2024 12:55


    A. Michael Lincoff and C. Michael Gibson discuss the cardiovascular impact of semaglutide in patients with overweight or obesity but without diabetes.

    The MINT Trial

    Play Episode Listen Later Apr 17, 2024 10:44


    Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.

    The ORBITA-2 Trial

    Play Episode Listen Later Apr 3, 2024 21:21


    Christopher Rajkumar, Rasha Al-Lamee, and C. Michael Gibson discuss this randomized trial of PCI versus a placebo procedure for stable angina.

    The ARIE-HM3 Trial

    Play Episode Listen Later Mar 14, 2024 14:49


    Mandeep Mehra and C. Michael Gibson discuss whether or not aspirin is needed for patients with left ventricular assist devices in advanced heart failure.

    The AZALEA - TIMI Trial

    Play Episode Listen Later Mar 11, 2024 13:15


    Christian T. Ruff and C. Michael Gibson discuss the primary results of a randomized trial testing the efficacy of abelacimab versus rivaroxaban for stroke prevention in atrial fibrillation.

    trial michael gibson christian t ruff
    The heart-1 Trial of VERVE-101

    Play Episode Listen Later Feb 21, 2024 5:16


    Andrew Bellinger, Sek Kathiresan, and C. Michael Gibson talk about the phase 1b trial of what investigators hope may be a one-time genetic fix for hyperlipidemia.

    Lepodisiran Phase I Trial

    Play Episode Listen Later Feb 7, 2024 5:22


    Steven Nissen and C. Michael Gibson discuss the efficacy and safety of lepodisiran, an extended duration short-interfering RNA meant to reduce lipoprotein (a).

    CLEAR Outcomes Subanalysis

    Play Episode Listen Later Jan 24, 2024 10:15


    Paul Ridker and C. Michael Gibson discuss whether residual inflammatory risk or residual cholesterol risk is a more effective predictor of CV events among patients treated with statins.

    The AXIOMATIC - SSP Trial

    Play Episode Listen Later Jan 10, 2024 8:35


    Mike Sharma and C. Michael Gibson discuss managing acute thromboembolic events in secondary stroke using antithrombotic treatment with factor XIa inhibition.

    The EBRAVE - AF Trial

    Play Episode Listen Later Jan 3, 2024 9:01


    Axel Bauer and C. Michael Gibson talk about whether smartphone-based screening can effectively detect atrial fibrillation in elderly, at-risk patients.

    The INVICTUS Trial

    Play Episode Listen Later Dec 7, 2023 17:01


    Ganesan Karthikeyan and C. Michael Gibson compare the efficacy of rivaroxaban versus vitamin K agonists for patients with rheumatic heart disease associated atrial fibrillation

    The FRAME-AMI Trial

    Play Episode Listen Later Oct 4, 2023 9:07


    Joo-Yong Hahn and C. Michael Gibson compare FFR with angiography-guided PCI for patients with acute myocardial infarction and multivessel disease.

    MASTER DAPT: Long-Term Results

    Play Episode Listen Later Sep 13, 2023 5:58


    Marco Valgimigli and C. Michael Gibson discuss the long-term follow-up results from MASTER DAPT, which compared the outcomes of high bleeding risk patients randomized to either abbreviated or standard antiplatelet therapy.

    Episode 180: The PANTHER Trial

    Play Episode Listen Later Sep 6, 2023 8:19


    Marco Valgimigli and C. Michael Gibson discuss the PANTHER trial, which compared P2Y12 inhibitor monotherapy with aspririn monotherapy in patients with coronary artery disease.

    Radial vs. Femoral Access for PCI: Meta-Analysis

    Play Episode Listen Later Aug 24, 2023 9:44


    Giuseppe Gargiulo and C. Michael Gibson discuss whether the choice of radial or femoral artery access impacts the risk of mortality and major bleeding for patients undergoing coronary procedures.

    Episode 181: ACT Outpatient and Inpatient Trials

    Play Episode Listen Later Aug 9, 2023 5:39


    Sanjit Jolly and C. Michael Gibson discuss if colchicine and rivaroxaban plus aspirin can slow disease progression in patients hospitalized with COVID-19.

    Episode 180: The VALOR-HCM Trial

    Play Episode Listen Later Aug 2, 2023 9:35


    Milind Desai and C. Michael Gibson compare the results of mavacamten for severe obstructive hypertropic cardiomyopathy with the typical treatments of surgical septal myectomy or alcohol ablation.

    Episode 179: The SODIUM-HF Study

    Play Episode Listen Later Jul 12, 2023 10:57


    Justin Ezekowitz and C. Michael Gibson look at a sodium-reducing dietary intervention and its effects on patients with HF.

    Episode 178: The COMPLETE Trial

    Play Episode Listen Later Jul 5, 2023 7:44


    Shamir Mehta and C. Michael Gibson discuss how complete revascularization affects angina-related quality of life in patients with STEMI.

    Episode 177: The EDIT-CMD Trial

    Play Episode Listen Later Jun 14, 2023 10:45


    Tijn Jansen, Suzette Elias-Smale, and C. Michael Gibson discuss whether diltiazem improves coronary vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease.

    Episode 176: The IVVE Trial

    Play Episode Listen Later May 24, 2023 7:21


    Mark Loeb and C. Michael Gibson discuss whether the influenza vaccine can reduce adverse vascular events among patients with HF.

    Episode 175: The METEORIC-HF Trial

    Play Episode Listen Later May 17, 2023 8:53


    Gregory Lewis and C. Michael Gibson discuss how omecamtiv mecarbil affects exercise tolerance in patients with chronic HFrEF.

    Episode 174: The DIAMOND Trial

    Play Episode Listen Later May 3, 2023 7:50


    Javed Butler and C. Michael Gibson discuss using patiromer to manage hyperkalemia in patients with HFrEF who are taking RAAS inhibitors.

    Claim Talking Points

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel